Clinical Trial Update: Cidofovir in Renal Transplant Recipients With BKVN [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated cidofovir for BK virus nephropathy in kidney transplant recipients; the study was terminated and results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bk Virus Nephropathy

Drugs mentioned

• Vistide (cidofovir) (cidofovir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: BK Virus (Nephropathy) | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2013-01-07